Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis.
Ontology highlight
ABSTRACT: Peroxisome proliferator activated receptor α (PPARα) has the most relevant biological functions among PPARs. Activation by drugs and dietary components lead to major metabolic changes, from reduced triglyceridemia to improvement in the metabolic syndrome. Polymorphisms of PPARα are of interest in order to improve our understanding of metabolic disorders associated with a raised or reduced risk of diseases. PPARα polymorphisms are mainly characterized by two sequence changes, L162V and V227A, with the latter occurring only in Eastern nations, and by numerous SNPs (Single nucleotide polymorphisms) with a less clear biological role. The minor allele of L162V associates with raised total cholesterol, LDL-C (low-density lipoprotein cholesterol), and triglycerides, reduced HDL-C (high-density li
SUBMITTER: Ruscica M
PROVIDER: S-EPMC6770475 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA